United States · Funded startup

Who invested in Elutia

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$13Mraised across 1 round since 2024, from 1 source

Latest round
Round, $13MJun 2024
Investors
1
See who backed them

The rounds

  1. Jun 2024
    Round$13M

    Source recorded

Founders and team

From the SEC filings it signed: 4 on the team.

  • C. Randal MillsPresident, Chief Executive Officeri
  • Jeffrey Randal HametSenior Vice President - Finance, Treasurer and Secretaryi
  • Matthew FergusonChief Financial Officeri
  • Michelle LeRoux WilliamsChief Scientific Officeri

On the board, as filediBrigid A. MakesDavid Matthew ColpmanKevin Matthew RakinMaybelle Matthew JordanW. Matthew Zuga

Everyone who backed them

DeerfieldVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Elutia as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

HighCape PartnersVC firmPer its own site

Quick answers about Elutia

Who invested in Elutia?

Elutia's investors include Deerfield.

How much has Elutia raised?

Elutia has raised $13M across 1 round since 2024.

When did Elutia last raise?

Elutia's most recent round was an Undisclosed round of $13M in Jun 2024.

What was Elutia's biggest round?

Its most recent round, $13M in Jun 2024, is also its largest on record.

Who backed Elutia first?

Elutia's first round on record, in Jun 2024, was backed by Deerfield.

What stage is Elutia at?

Elutia's latest named round is an Undisclosed round, in Jun 2024.

Where is Elutia based?

Elutia is based in the United States.

Companies like Elutia

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.